Predictors of orphan drug approval

Similar Items

• No difference in between-country variability in use of newly approved orphan and non- orphan medicinal products - a pilot study
  by: Bloechl-Daum Brigitte, et al.
  Published: (2009-12-01)
• International comparison of availability for orphan drugs: focused on approved orphan drugs in South Korea
  by: Eun Young Shin, et al.
  Published: (2024-12-01)
• Lifecycle management of orphan drugs approved in Japan
  by: Kiyoshi Seki, et al.
  Published: (2022-07-01)
• Leveraging existing opportunities for improved Orphan Drug approval in the EU
  by: Edfjäll Catarina
  Published: (2012-11-01)
• A comprehensive study of the rare diseases and conditions targeted by orphan drug designations and approvals over the forty years of the Orphan Drug Act
  by: Lewis J. Fermaglich, et al.
  Published: (2023-06-01)